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Summary
 
RelB-deficient mice (
 
relB
 
2
 
/
 
2
 
) have a complex phenotype including multiorgan inflammation
and hematopoietic abnormalities. To examine whether other NF-
 
k
 
B/Rel family members are
required for the development of this phenotype or have a compensatory role, we have initiated
a program to generate double-mutant mice that are deficient in more than one family member.
Here we report the phenotypic changes in 
 
relB
 
2
 
/
 
2
 
 mice that also lack the p50 subunit of NF-
 
k
 
B (
 
p50
 
2
 
/
 
2
 
). The inflammatory phenotype of 
 
p50
 
2
 
/
 
2
 
relB
 
2
 
/
 
2
 
 double-mutant mice was mark-
edly increased in both severity and extent of organ involvement, leading to premature death
within three to four weeks after birth. Double-knockout mice also had strongly increased my-
eloid hyperplasia and thymic atrophy. Moreover, B cell development was impaired and, in
contrast to 
 
relB
 
2
 
/
 
2
 
 single knockouts, B cells were absent from inflammatory infiltrates. Both
 
p50
 
2
 
/
 
2
 
 and heterozygous 
 
relB
 
2
 
/
 
1
 
 animals are disease-free. In the absence of the p50, however,
 
relB
 
2
 
/
 
1
 
 mice (
 
p50
 
2
 
/
 
2
 
relB
 
2
 
/
 
1
 
) had a mild inflammatory phenotype and moderate myeloid hy-
perplasia. Neither elevated mRNA levels of other family members, nor increased 
 
k
 
B-binding
activities of NF-
 
k
 
B/Rel complexes could be detected in single- or double-mutant mice com-
pared to control animals. These results indicate that the lack of RelB is, in part, compensated
by other p50-containing complexes and that the “classical” p50-RelA–NF-
 
k
 
B activity is not
required for the development of the inflammatory phenotype.
 
C
 
ellular decisions involved in growth, differentiation,
and development require the coordinated expression
of a wide variety of genes. The transcriptional regulation of
genes is mediated by factors that bind singly or in associa-
tion with other proteins to 
 
cis
 
-regulatory sequences found
in promoters, enhancers, and silencers. These transcription
factors frequently form families in which individual mem-
bers have distinct or similar functions.
The NF-
 
k
 
B/Rel family of transcription factors represents
a group of homodimeric and heterodimeric complexes that
plays an important role in the function of lymphocytes and
other cells of hematopoietic origin. Five members of this
family have been identified in vertebrates: NF-
 
k
 
B1 (en-
coding the precursor molecule p105 that is proteolytically
processed to p50), NF-
 
k
 
B2 (encoding the precursor p100
and the processed form of p52), RelA (p65), RelB, and
c-Rel (Rel). One hallmark of the family is a highly con-
served domain of 
 
z
 
300 amino acids, termed the Rel ho-
mology domain, that contains sequences important for
dimerization, DNA binding, and nuclear localization. In most
cell types NF-
 
k
 
B/Rel proteins associate with the inhibitor
molecule I
 
k
 
B forming an inactive cytoplasmic complex that
can be activated by a wide range of stimuli leading to deg-
radation of I
 
k
 
B and nuclear translocation of the NF-
 
k
 
B/
Rel proteins and their binding to so-called 
 
k
 
B sequence
motifs. Many target genes are involved in immune, inflam-
matory, acute phase, and stress responses (1–7).
Recent evidence using mice with targeted disruptions
for individual members of the NF-
 
k
 
B/Rel family indicates
that the different proteins play distinct biological roles. For
example, p50-deficient mice appear normal and lympho-
cyte development is not impaired. However, these animals
have multifocal defects in immune responses and B cells are
defective in mitogenic activation and specific antibody pro-
duction (8, 9). Mice with a targeted disruption of RelA are
embryonic lethal due to a defect in liver development (10).
Mature B and T cells from mice that lack c-Rel were found
to be unresponsive to most mitogenic stimuli (11, 12).
RelB, originally identified as an immediate-early gene in
growth factor-induced fibroblasts (13, 14), is expressed pre-
dominantly in lymphoid tissues where RelB heterodimers
represent the major constitutive 
 
k
 
B-binding activity (15–18).
In thymus, 
 
relB
 
 transcripts are confined to the medulla and
high levels of RelB are expressed in the nucleus of inter-
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digitating dendritic cells (DC)
 
1
 
. In addition, lower levels of
RelB expression can be detected in macrophages as well as
B and T cells (15, 16, 18–20).
Mice with a targeted disruption of RelB have pathologi-
cal changes including inflammatory cell infiltration in sev-
eral organs, myeloid hyperplasia, and splenomegaly due to
extramedullary hematopoiesis. RelB is also required for the
normal development of thymic medulla and antigen-pre-
senting DC. Besides the pathological changes, RelB-defi-
cient mice have multifocal defects in cellular and humoral
immune responses (21 and 21a). Similarly, a mutation dis-
rupting the 
 
relB
 
 locus by the random integration of trans-
gene sequences resulted in mice with a syndrome of excess
production of macrophages and granulocytes, reduced pop-
ulations of thymic dendritic and medullary epithelial cells,
and impaired antigen-presenting cell function (22).
Different NF-
 
k
 
B/Rel complexes have different sequence
preferences and transcriptional activation properties. How-
ever, the DNA binding domain is highly conserved between
NF-
 
k
 
B/Rel family members and p50-RelA, p50-RelB, or
p50-c-Rel heterodimers can bind to similar regulatory 
 
k
 
B
sequences and activate transcription of target genes (23–25).
Although the phenotypic changes in 
 
relB
 
2
 
/
 
2
 
 mice show that
RelB function is crucial for a normal hematopoietic system
(21, 22), it is possible that other members of the NF-
 
k
 
B/
Rel family may, at least in part, functionally compensate for
the lack of RelB. p50-deficient mice do not have any
pathological changes and the absence of the “classical” p50-
RelA–NF-
 
k
 
B activity as well as other p50-containing
NF-
 
k
 
B/Rel complexes (8) make this mutant mouse line a
useful model system to address functional redundancy
within the NF-
 
k
 
B/Rel family. In addition, 
 
p50
 
2
 
/
 
2
 
relB
 
2
 
/
 
2
 
double-knockout mice may provide an answer to the ques-
tion of whether p50-RelA–NF-
 
k
 
B complexes are required
in the effector cells that mediate the 
 
relB
 
2
 
/
 
2
 
 phenotype.
In this report we compare the phenotype of 
 
p50
 
2
 
/
 
2
 
 and
 
relB
 
2
 
/
 
2
 
 single-mutant, 
 
p50
 
2
 
/
 
2
 
relB
 
2
 
/
 
2
 
 double-mutant, and
 
p50
 
2
 
/
 
2
 
relB
 
2
 
/
 
1
 
 mice, and focus on the different cell types
involved in the pathological changes observed in these ani-
mals. The results indicate that the lack of RelB is partially
compensated by other p50-containing complexes and that
the p50-RelA–NF-
 
k
 
B activity is not essential for the de-
velopment of the inflammatory phenotype in RelB-defi-
cient mice.
 
Materials and Methods
 
Mice.
 
RelB- and p50-deficient mice were originally estab-
lished from 
 
relB
 
2
 
/
 
1
 
 (129/Sv 
 
3
 
 C57BL/6J background) and 
 
p50
 
2
 
/
 
1
 
(129/Ola 
 
3
 
 C57BL/6J background) mice, respectively, and were
subsequently maintained by intercrosses (8, 21). Tail DNA was
prepared as described (26). The genotype of RelB-deficient mice
was determined by PCR amplification (1 min at 95
 
8
 
C, 1.5 min at
60
 
8
 
C, and 1 min at 72
 
8
 
C for 33 cycles) using primer pairs recog-
nizing the intact 
 
relB
 
 gene (5
 
9
 
-GTG GTG CCC GGG AAT
 
AGG ATT GCT G-3
 
9
 
 and 5
 
9
 
-CCA TTT TGC TCT GGG
TCT GTG TCT G-39) and the targeted relB-neo locus (59-CAT
CGA CGA ATA CAT TAA GGA GAA CGG-39 and 59-AAA
TGT GTC AGT TTC ATA GCC TGA AGA ACG-39). PCR
amplification conditions for p50-deficient mice were 1 min at
958C and 2 min at 668C for 30 cycles using primers specific for
the intact nfkb1 gene (59-GCA AAC CTG GGA ATA CTT
CAT GTG ACT AAG-39 and 59-ATA GGC AAG GTC AGA
ATG CA CAG AAG TCC-39) and the targeted nfkb1-neo locus
(59-AAA TGT GTC AGT TTC ATA GCC TGA AGA ACG-
39). All animals were housed and bred within the same room (in
Veterinary Sciences Department of Bristol-Myers Squibb Phar-
maceutical Research Institute, Princeton, NJ). The absence of
pathogens was assessed by extensive, periodic, comprehensive se-
rology, and histopathology of sentinel animals housed within the
same room.
Histopathology and Immunohistochemistry. Histopathological analy-
ses were performed on a minimum of three animals per age group
and genotype. Tissues were immersion-fixed in 10% buffered for-
malin, embedded in paraffin blocks, and processed by routine
methods. Sections (4–6 mm thick) were stained with hematoxylin
and eosin, and examined by light microscopy. For immunohis-
tochemical staining of CD41 and CD81 T cells, tissues were fro-
zen in O.C.T.-embedding medium (Miles Inc., Elkhart, IN),
sectioned at 8 mm, and immediately fixed in buffered formalin/
acetone. Sections were blocked with avidin D/biotin reagents
(Vector Labs., Inc., Burlingame, CA), followed by 0.5% casein in
PBS, and incubated with purified CD4- or CD8-specific mAb
from PharMingen (San Diego, CA; clone RM4-5 diluted 1;50 and
clone  53-6.7 diluted 1;20, respectively) for 180 min at room
temperature. For immunohistochemical staining of B cells, ma-
ture macrophages, and neutrophils, formalin-fixed paraffin sec-
tions were treated with 0.1% trypsin at 378C for 20 min, blocked
with avidin D/biotin reagents and normal mixed serum (Shandon
Inc., Pittsburgh, PA), and incubated with purified specific mAbs
(clone RA3-6B2 diluted 1;300 [PharMingen] and clone F4/80 di-
luted 1;10 and clone 7/4 diluted 1;50 [both from Harlan Bio-
products for Science Inc., Indianapolis, IN]) for 90 min a room
temperature. Endogenous peroxidase activity was quenched in 3%
hydrogen peroxide in PBS for 10 min at room temperature. In-
cubation with a biotinylated secondary Ab (mouse-absorbed anti–
rat IgG from rabbit, diluted 1;100) was for 30 min, followed by
avidin-linked peroxidase for 30 min, followed by diaminoben-
zidine chromogen for 3 min, and hematoxylin counterstain for 1
min. Unless otherwise stated, all reagents were obtained from
Vector Labs., Inc. For negative control slides, the primary Ab was
substituted with normal mixed serum.
Flow Cytometry. Flow cytometry was done using a flow cy-
tometer and cell sorter (Coulter Epics Profile II; Coulter Corp.,
Hialeah, FL). Splenocytes and bone marrow cells were isolated
and mature red blood cells were lysed according to standard pro-
cedures (27). Cell suspensions were incubated with mAbs (<1 mg
each/106 cells) for 30 min on ice, spun, and washed with PBS/2%
fetal calf serum. Conjugated CD4-FITC, CD8-PE, and CD45R/
B220-FITC mAbs were obtained from GIBCO BRL (Gaithers-
burg, MD); TCR-a/b-FITC, IgM-FITC, and Gr-1-FITC mAb
were from PharMingen; Mac-1-PE mAb was from Boehringer
Mannheim (Indianapolis, IN). An average of 104 cells was re-
corded in each case.
Semi-Quantitative Reverse Transcription–PCR Analyses. Total thy-
mus RNA from 2-wk-old mice was isolated using TRIzol ac-
cording to the manufacturer’s instructions (GIBCO BRL). cDNA
was synthesized from 2 mg total RNA (Superscript Preamplifica-
1Abbreviations used in this paper: DC, dendritic cells; DOC, deoxycholate;
DP, double positive; EMSA, electrophoretic mobility shift assays.1361 Weih et al.
tion System; GIBCO BRL). Semi-quantitative PCR was performed
under conditions where amplification of the cDNAs was linearly
dependent on the concentration of the corresponding mRNAs
(28, 29). The sequences of the primers were: for nfkb1, 59-GCA
CCG TAA CAG CAG GAC CCA AGG ACA-39 and 59-CCC
GTC ACA CAT CCT GCT GTT CTG TCC ATT CT-39; for
nfkb2, 59-GCC TGG ATG GCA TCC CCG-39 and 59-CTT
CTC ACT GGA GGC ACC T-39; for relA, 59-TAG CCT TAC
TAT CAA GTG TCT TCC TCC-39 and 59-GTT CAG AGC
TAG AAA GAG CAA GAG TCC-39; for relB, 59-CCT CTC
TTC CCT GTC ACT AAC GGT CTC-39 and 59-ACG CTG
CTT TGG CTG CTC TGT GAT G-39; for c-rel, 59-TGG
CTG ACT GAC TCA CTG ACT GAC TGA CTC GTG CCT
TGC-39 and 59-CCA ACT AAA TCA TGA GGA TGA GGC
TTA TAT GGA TCA TTC-39; for ikba, 59-CAG GAC TGG
GCC ATG GAG GG-39 and 59-TGG CCG TTG TAG TTG
GTG GC-39; for ikbb, 59-CCC TTC CTG GAT TTC CTC
CTG GGC TTT TC-39 and 59-GTG GGG TCA GCA CCG
GCT TTC AGG AGA-39; and for b-actin, 59-AGA GGT ATC
CTG ACC CTG AAG TAC C-39 and 59-CCA CCA GAC
AAC ACT GTG TTG GCA T-39.
Electrophoretic Mobility Shift Assays. Whole cell extracts from
2-wk-old thymuses were prepared as described (16). The oli-
godeoxynucleotide comprising a palindromic, kB-binding site
has been described previously (13, 24). 4 mg of thymus extract
were incubated with 10 fmol of the radiolabeled probe in 10 mM
Tris 3 HCl, pH 7.5, 50 mM NaCl, 1 mM EDTA, 5 mM dithiothre-
itol, 5% glycerol, and 0.6 mg herring sperm DNA; kB-binding ac-
tivity was analyzed in electrophoretic mobility shift assays (EMSAs)
as previously described (18). Extracts were activated by treatment
with 0.6% deoxycholate (DOC) for 15 min on ice followed by
the addition of NP-40 to a final concentration of 1.2%. As a con-
trol, binding of unactivated extracts was also performed in the
presence of 1.2% NP-40. Integrity of extracts was checked with
an octamer binding site.
Results
Increased Mortality of p502/2relB2/2 Double-knockout Mice.
Mice with a targeted deletion of p50 are fertile, whereas
the majority of RelB-deficient mice are sterile due to
marked inflammatory infiltrates in the reproductive organs
of males and females older than 40 d (8, 21). Therefore, the
p502/2 mutation was crossed into a relB2/1 background
generating p502/2relB2/1 animals that were interbred to ob-
tain p502/2relB2/2 double-mutant mice. The resulting lit-
ters were normal in size, all animals appeared healthy at
the time of birth, and p502/2relB1/1, p502/2relB2/1, and
p502/2relB2/2 mice were born at expected Mendelian ra-
tios, demonstrating that p502/2relB2/2 double-knockout
mice can develop to birth (data not shown).
2–3 wk after birth, however, all the p502/2relB2/2 ani-
mals were runted, lethargic, had abdominal distension, and
their body weights were reduced 30–50%, compared to
control littermates; relB2/2 mice of the same age were less
severely affected (Fig. 1 A). The disease progressed rapidly
in p502/2relB2/2 mice leading to premature death of .95%
of the animals between 2 and 4 wk of age (Fig. 1 B). relB2/2
single-knockout mice also had increased mortality, but
only 33% died within the first 4 wk after birth. Heterozy-
gous relB2/1 on a wild-type or p502/2 background did not
have increase mortality, although several p502/2relB2/1 mice
of 5 mo and older appeared sick and died prematurely (Fig. 1
B and data not shown). At necropsy of 20-d-old mice,
marked thymic atrophy, splenomegaly, and liver and kid-
ney turgidity were observed in all p502/2relB2/2 double
knockouts. Moderate thymic atrophy and splenomegaly
was observed in relB2/2 single-knockout animals. Wild-
type controls, p502/2 single knockouts, and relB2/1 mice
were nonremarkable (Fig. 1 C and data not shown).
Multiorgan Inflammation: Increased Severity and Extent in
p502/2relB2/2 Double-knockout Mice. The histopathologi-
cal findings in 20-d-old mice of various genotypes are sum-
marized in Table 1. No changes were observed following
an extensive histopathological examination of lymphoid and
nonlymphoid tissues from several wild-type, relB2/1, and
p502/2 animals. A minimal inflammatory phenotype ac-
companied by a moderate myeloid hyperplasia occurred in
heterozygous relB2/1 mice in the absence of p50 (p502/2
relB2/1). relB2/2 single-knockout mice had a moderate
multiorgan infiltrate.
In contrast, p502/2relB2/2 double-knockout mice by
day 20 developed an inflammatory infiltrate that was of
Table 1. Histopathology Summary of 3–4 wk-old Mice of Different Genotypes
p502/2 p502/2relB2/1 relB2/2 p502/2relB2/2
Thymus NR NR G2-3 atrophy G4 atrophy
Spleen NR G1 EMH G2-3 EMH G4 EMH
Bone marrow NR G1 MH G2-3 MH G4 MH
Lung NR G1 PV LC G3 PV MXE G4 PV MXE
Liver NR G1 PP MX G3 PP MXE G4 PP MXE
Kidney NR NR NR G3 PV MNE
Heart NR NR NR G2 MN
NR, nonremarkable (as compared to similarly aged wild-type and relB2/1 mice) G1, minimal; G2, mild; G3, moderate; G4, marked; EMH, ex-
tramedullary hematopoiesis; MH, myeloid hyperplasia; PV, perivascular; PP, periportal; LC, lymphocytes; MX, mixed (both polymorphonuclear and
mononuclear cells); E, extending into the surrounding parenchyma from a perivascular or periportal orientation; MN, mononuclear cells.1362 Severely Increased Pathology in p502/2relB2/2 Double-knockout Mice
greater severity and extent of organ system involvement as
compared to relB2/2 single-knockout animals. Interest-
ingly, 8–10-d-old p502/2relB2/2 mice were only slightly
more affected than similarly aged relB2/2 animals. Thereaf-
ter, the infiltrate in RelB-deficient mice progressed much
more rapidly and aggressively in the absence of the p50 sub-
unit of NF-kB, and was reflected by increased mortality (Fig.
1 B and data not shown). Similar to relB2/2 single-knock-
out animals, the lung and liver were also markedly affected
in p502/2relB2/2 double-knockout mice. In the lung of
Figure 1. (A) Gross appearance of 20-d-old
wild-type (right), relB2/2 (left), and p502/2relB2/2
(middle) mice. (B) Survival of relB2/1, p502/2
relB2/1, relB2/2, and p502/2relB2/2 mice. Sur-
viving mice expressed as a percentage of the ini-
tial number of animals in each genotype group
are plotted. relB2/1 mice (s); p502/2relB2/1
mice (d); relB2/2 mice (h); and p502/2relB2/2
mice (j). (C) Thymus (Th), spleen (Sp), liver
(Li), and kidney (Ki) from 20-d-old wild-type,
relB2/2, and p502/2relB2/2 animals. Genotypes
are indicated at the bottom.
Figure 2. Histopathological
analysis of wild-type, p502/2,
relB2/2, and p502/2relB2/2 mice.
Lung (A–D), kidney (E–H), and
heart (I–L) sections from 20-d-old
mice stained with hematoxylin
and eosin. (A, E, and I) Wild-
type control; (B, F, and J) p502/2
single mutant; (C, G, and K)
relB2/2 single mutant; (D, H,
and L) p502/2relB2/2 double
mutant. Bars: (A–D), 100 mm;
(E–L), 50 mm.1363 Weih et al.
double-knockouts, the infiltrate was in a perivascular and
periairway orientation that extended into and effaced the
surrounding parenchyma, whereas in the relB2/2 single
knockouts, the infiltrate was predominantly restricted to a
perivascular orientation (Fig. 2 A–D). In the liver of relB2/2
and p502/2relB2/2 mice, the infiltrate originated in peri-
portal areas and extended into surrounding hepatocellular
trabeculae and sinusoids. However, the infiltrate in double-
knockout animals was so severe that infarction was com-
monplace, most likely resulting from infiltrate-induced in-
terference with vascular flow (data not shown). In addition,
the inflammatory infiltrate of 20-d-old double-knockout
mice also involved kidney (Fig. 2, E–H), heart (Fig. 2, I–L),
striated musculature, and salivary glands, organs that were
not affected in 3-wk-old relB2/2 single-knockout mice.
Myeloid hyperplasia in the bone marrow and spleen was
also more pronounced in double knockouts as compared to
relB2/2 single-knockout animals (data not shown).
Role of T Cells, B Cells, Macrophages, and Neutrophils in the
Inflammatory Phenotype. To examine the cellular composi-
tion of the inflammatory infiltrates in nonlymphoid tissues
in more detail, lung and liver sections from 20-d-old wild-
type controls, relB2/2, and p502/2relB2/2 mice were ana-
lyzed by immunohistochemical criteria. Only resident leu-
kocyte populations were detected in control tissues stained
with the different mAbs (Fig. 3, A and D; and Fig. 4, A, D,
and G). In contrast, abundant staining was observed in pul-
monary infiltrates of both relB2/2 and p502/2relB2/2 mice
with mAbs specific for CD41 helper T cells (Fig. 3, B and
C) and CD81 cytotoxic T cells, although a smaller number
of CD81 lymphocytes occurred both quantitatively and
proportionally in the infiltrates of double-knockout mice
(Fig. 3 E and F). Prominent infiltrates, consisting predomi-
nantly of CD41 and CD81 lymphocytes, were observed in
the lung and liver of these animals as early as 10 d after
birth, suggesting that T cells are crucially involved in the
onset of the inflammatory phenotype (data not shown).
To examine which non–T cell types are involved in the
inflammatory infiltrates, liver sections from 20-d-old wild-
type, relB2/2, and p502/2relB2/2 mice were stained with
mAbs specific for B cells, macrophages, and neutrophils
(Fig. 4). B cells were readily detected within the periportal
infiltrate in sections from relB2/2 mice (Fig. 4 B). In marked
contrast, the inflammatory infiltrate in p502/2relB2/2 liver
contained very few B cells (Fig. 4 C), indicating that B
cells are not required for the development of the inflam-
matory phenotype in p502/2relB2/2 animals. Kupffer cells,
specialized tissue macrophages residing along hepatic sinu-
soids, showed strong positive staining in wild-type mice as
compared to relB2/2 and p502/2relB2/2 animals (Fig. 4, D–F).
Little F4/80-positive staining was detected within the infil-
trates of single- and double-knockout mice (Fig. 4, E and F).
This finding, coupled with the observation that few infil-
trative cells had morphological criteria of macrophages,
suggest that this cell population is not a prominent compo-
nent of the inflammatory phenotype of these animals at this
age. Since adult RelB-deficient mice have increased granu-
lopoiesis in bone marrow and spleen (21, 22), we examined
whether polymorphonuclear leukocytes are an important
component of the inflammatory infiltrates. Markedly in-
creased numbers of neutrophils were detected in the peri-
portal infiltrates of p502/2relB2/2 mice compared to relB2/2
animals (Fig. 4, G–I). Similar results were obtained when
lung sections were stained for B cells, macrophages, and
neutrophils (data not shown).
Increased Myeloid Hyperplasia and Impaired B Cell Develop-
ment in p502/2relB2/2 Mice. Flow cytometric analysis of
3-wk-old p502/2relB2/2 double-knockout mice revealed
marked alterations in thymus, spleen, and bone marrow cell
subpopulations. Mice deficient in the p50 subunit of NF-
kB, like heterozygous relB2/1 mice, do not have any
changes compared to wild-type animals (8, 21; data not
shown) and were used as controls. We also included relB2/1
mice on a p502/2 background (p502/2relB2/1) since these
animals develop a mild inflammatory phenotype (see Table 1).
CD41CD81 double positive (DP) TCRlo thymocytes were
dramatically reduced in double knockouts, whereas CD81
and, in particular, CD41 single positive TCRhi T cells were
relatively increased (Fig. 5 A). Mature T cells were present
in p502/2relB2/2 spleen whereas B2201IgM1 B cells were
markedly reduced. In contrast, numbers of myeloid cells
(Mac-11, Gr-11, 7/41) were dramatically increased (Fig. 5
B and data not shown). With respect to the reduced num-
ber of B cells, p502/2relB2/2 double-knockout spleens
were characterized by poorly-developed B cell follicles, hy-
perplastic periarterial lymphatic sheath (T cell) areas, and
indiscrete marginal zones (data not shown). Flow cytomet-
ric analysis of bone marrow cells also revealed increased
numbers of myeloid cells and markedly reduced B2201
IgM2 and B2201IgM1 B cell populations (Fig. 5 C). Inter-
estingly, p502/2relB2/1 mice also had a moderate reduction
in splenic B cells and increased numbers of myeloid cells in
the bone marrow, but normal T cell subsets in thymus and
spleen (Fig. 5, A–C).
Since the interpretation of the results obtained from 3–4-wk
old animals is hampered by the severe pathological changes
in lymphoid organs of p502/2relB2/2 double-knockout
mice, we analyzed 2-wk-old animals by flow cytometry. At
this age, both relB2/2 and p502/2relB2/2 mice show a milder
phenotype, and the pathological differences between these
two mutant lines are less pronounced. Wild-type animals
were included as a control; similar results were obtained
with p502/2 or relB2/1 mice (data not shown). Similar to
the results shown in Fig. 5, although less severe, 2-wk-old
p502/2relB2/2 mice had decreased numbers of DP thymocytes
and an increased population of thymic CD41TCRhi T cells
(Fig. 6 A). T cell subsets in double-knockout spleen were
normal, but both B2201IgM2 and B2201IgM1 B cell pop-
ulations were reduced, and the number of myeloid cells
was increased (Fig. 6 B). Similarly, the number of Gr-11
cells was increased in double-knockout bone marrow while
both B cell subpopulations were markedly reduced (Fig. 6
C). In contrast, relB2/2 mice of the same age had only
moderate myeloid hyperplasia in spleen and a very mild re-
duction in B2201IgM1 B cells compared to wild-type lit-
termates (Fig. 6 and data not shown).1364 Severely Increased Pathology in p502/2relB2/2 Double-knockout Mice
Figure 3. Immunohistochemical
detection of T cells in lungs from
20-d-old wild-type, relB2/2,
and  p502/2relB2/2 mice. (A–C)
Lung sections stained with an
mAb specific for CD41 T helper
cells. (D–F) Lung sections stained
with an mAb specific for CD81
cytotoxic T cells. (A and D)
Wild-type control; (B and E)
relB2/2 single mutant; (C and F)
p502/2relB2/2 double mutant.
Bars, 50 mm.
Figure 4. Immunohistochemical
detection of B cells, macrophages,
and neutrophils in liver from
20-d-old wild-type, relB2/2, and
p502/2relB2/2 mice. (A–C) Liver
sections stained with a B cell–spe-
cific mAb (B220). (D–F) Liver
sections stained with an mAb spe-
cific for macrophages (F4/80).
(G–I) Liver sections stained with
an mAb specific for neutrophils
(7/4). (A, D, and G) Wild-type
control; (B, E, and H) relB2/2 sin-
gle mutant; (C, F, and I) p502/2
relB2/2 double mutant. Arrows in
B and C mark the periportal in-
flammatory infiltrate. Bars, 50 mm.1365 Weih et al.
Figure 5. Flow cytometric analysis of 3-wk-old p502/2, p502/2relB2/1,
and p502/2relB2/2 mice. Thymus (A), spleen (B), and bone marrow (C)
single cell suspensions were analyzed for surface expression of CD4, CD8,
and TCR-a/b (T cells), B220 and IgM (B cells), Mac-1 (macrophages
and granulocytes), and Gr-1 (granulocytes). Genotypes are depicted above
representative plots. Numbers indicate subpopulation percentages.
Expression and DNA Binding of NF-kB/Rel Family Mem-
bers in Single- and Double-mutant Mice. To examine whether
there is any compensatory upregulation of other family
members in mice lacking p50, RelB, or both, mRNA levels
of all NF-kB/Rel family members and IkBa/b in thymus
were determined by semi-quantitative reverse transcrip-
tion–PCR. Expression of b-actin was used as a reference
(Fig. 7). Whereas nfkb1 and relB transcripts were absent in
the respective mutant lines, mRNAs specific for relA, c-rel,
ikba, and ikbb were readily detected in all genotypes exam-
ined. Expression of these genes was not significantly altered
but nfkb2 mRNA levels were reduced in both single- and
double-mutant mice, suggesting that nfkb2 expression may
be regulated by p50–RelB heterodimers. Interestingly, p52
protein levels were only slightly reduced in extracts from
single- or double-knockout mice (8, 21; data not shown).
These results indicate that there is no compensatory upreg-
ulation of other NF-kB/Rel family members in the ab-
sence of p50, RelB, or both.
To correlate mRNA levels with kB-binding activity,
EMSA with thymus extracts from wild-type, p502/2, relB2/2,
and p502/2relB2/2 mice were performed (Fig. 8). The kB-
binding activity was strongly reduced in both p502/2 and
relB2/2 single-mutant mice (8, 21) and almost completely
abolished in p502/2relB2/2 double-mutant thymus (Fig. 8
A, lanes 1–4). Challenge with anti-p52 (lanes 5–8) and
anti-RelA (lanes 9–12) antiserum reduced the respective
binding complexes in wild-type or single-mutant mice, and
did not reveal any new homodimers or heterodimers in
mice lacking p50, RelB, or both. The complex in extracts
from p50-deficient single knockouts consisted of p52–
RelB heterodimers since it was reduced in relB2/2 mice
(lanes 3 and 4) and in the presence of anti-p52 antiserum
(lanes 2 and 6). We were unable to detect significant bind-
ing of c-Rel under these conditions, and only the very
weak kB-binding activity that remained in extracts from
double-knockout mice was reduced by antiserum directed
against c-Rel, p52, or RelA (lanes 4, 8, 12, and data not
shown). Integrity of extracts was checked with an octamer
binding site (lanes 13–16). Also, no compensatory com-
plexes could be detected in spleen extracts or with kB-
binding sites derived from the immunoglobulin k light
chain enhancer or the HIV LTR (data not shown).
In most cells, NF-kB/Rel activities are retained in an in-
activated form in the cytoplasm through their interaction
with the inhibitory proteins IkBa and IkBb or the p100
and p105 precursors. These inactive complexes, however,
can readily be activated by DOC treatment resulting in in-
creased kB-binding activity (30). Therefore, we analyzed
whether any new compensatory complexes can be found in
DOC-treated extracts from single- or double-mutant mice
(Fig. 8 B). Under these conditions, binding of p50 ho-
modimers in wild-type and relB2/2 extracts was signifi-
cantly reduced. In all activated extracts, an additional com-
plex of slower mobility could be observed, although the
signal was clearly reduced in the absence of p50, RelB, or
both (compare lanes 1–4 and 5–8). Challenge with anti-1366 Severely Increased Pathology in p502/2relB2/2 Double-knockout Mice
RelA and anti–c-Rel antiserum showed that this kB-bind-
ing activity most likely consisted of c-Rel homodimers and
c-Rel–RelA heterodimers, although RelA homodimers
could not be excluded since the anti–c-Rel antiserum
weakly cross-reacts against RelA (lanes 9–12 and 13–16
and data not shown). In any case, these complexes were
neither increased in single- nor double-mutant mice, indi-
cating the lack of compensatory kB-binding activities in
both single- and double-knockout mice.
Discussion
More than 10 potential homodimers and heterodimers
can be formed among members of the NF-kB/Rel family
of transcription factors that can bind to similar cis-regula-
tory sites and modulate gene expression. This results in a
high degree of complexity within this family of transcrip-
tion factors. Several reports of mice with targeted disrup-
tions of individual NF-kB/Rel family members demon-
strated that the different proteins play distinct biological
roles (6, 7). It is unclear, however, whether functional re-
dundancy also exists within this family that would result in
a (partial) compensation of the phenotype in single-knock-
out animals.
Severely Increased Pathology in p502/2relB2/2 Double-
knockout Mice. Both thymic atrophy and myeloid hyper-
plasia in bone marrow and spleen were markedly increased
in p502/2relB2/2 double-mutant mice compared to relB2/2
single-mutant animals. Also, multiorgan inflammation was
dramatically increased in severity and extent resulting in
premature death of all double-knockout mice. Another no-
table difference is the penetrance of the pathological changes
in thymus and other organs. The phenotype was markedly
increased in severity in all p502/2relB2/2 double knockouts
examined, whereas there was considerable interanimal vari-
Figure 7. RNA expression analysis in wild-type, p502/2, relB2/2, and
p502/2relB2/2 mice. Total thymus RNA was prepared from 2-wk-old
mice, reverse transcribed, and cDNAs were amplified by semi-quantita-
tive PCR using the indicated specific primers as described in Materials
and Methods. Gels were exposed for different times to compensate for
differences in the expression levels of individual family members.
Figure 6. Flow cytometric analysis of 2-wk-old wild-type, relB2/2,
and p502/2relB2/2 mice. Thymus (A), spleen (B), and bone marrow (C)
cell suspensions were analyzed for surface expression of CD4, CD8,
TCR-a/b (T cells), B220 and IgM (B cells), Gr-1 (granulocytes), and
F4/80 (macrophages). Genotypes are depicted above representative plots.
Numbers indicate subpopulation percentages.1367 Weih et al.
ation in relB2/2 single-knockout mice. Heterozygous relB2/1
mice that also lacked p50 had moderate pathological
changes that were qualitatively similar to homozygous
relB2/2 mice, further lending support to the notion that the
lack of RelB is partially compensated by other p50-con-
taining complexes.
There are examples to support the theory of functional
compensation within a family of related proteins. For in-
stance, embryos that are exposed to retinoic acid during de-
velopment have a wide spectrum of malformations. Whereas
the disruption of individual retinoic acid receptors did not
result in the expected phenotypes, double-mutant mice have
severe developmental abnormalities (31). Similarly, increased
severity in phenotypic changes was observed in mice with
combined deficiencies of the homeobox genes hoxa-3 and
hoxd-3 (32) or the tyrosine kinases Src, Fyn, and Yes (33).
Increased expression of a related family member as a com-
pensatory mechanism has been proposed for the myogenic
transcription factor Myo D. Mice with a targeted disrup-
tion of myo D do not have morphological abnormalities in
skeletal muscle, but do have markedly increased levels of
myf-5 mRNA. Simultaneous disruption of both myo D and
myf-5, however, results in a more severe phenotype (34).
Our results also suggest functional redundancy within the
NF-kB/Rel family and, in contrast to Myo-D–deficient
mice, we were unable to detect a compensatory upregula-
tion of other NF-kB/Rel family members in both single-
and double-knockout animals. Compared to relB2/2 sin-
gle-knockout mice, p502/2relB2/2 double knockouts also
lack p50–p50, p50–p52, p50–RelA, and p50–c-Rel com-
plexes. Thus, additional mouse mutants deficient for differ-
ent combinations of NF-kB/Rel proteins will be necessary
to further elucidate the network of redundancy and to un-
derstand the specific functions of each NF-kB/Rel family
member in more detail.
Role of T Cells in the relB2/2 Pathology. Several of the
histopathologic features and cellular constituents observed
in the lung of relB2/2 and p502/2relB2/2 mutant mice are
similar to those observed in certain human interstitial lung
diseases, including idiopathic pulmonary hemosiderosis (35),
Goodpasture’s syndrome (36), and acute systemic lupus ery-
thematosis with a hemorrhagic component (37, 38). The
inflammatory cell infiltration in p502/2relB2/2 mice, in
particular in the skeletal and cardiac musculature, kidney,
and salivary glands, resembles that seen in certain human
autoimmune diseases, including immune-mediated myo-
carditis and polymyositis, and Sjögren’s syndrome (39, 40).
Many experimental models have shown that T cells can be
pathogenic mediators in autoimmune diseases (41, 42). In-
deed, by using a transgenic mouse line that lacks T cells, we
Figure 8. NF-kB/Rel binding ac-
tivities in wild-type, p502/2, relB2/2,
and p502/2relB2/2 mice. (A) Thymus
extracts from 2-wk-old mice were in-
cubated with a palindromic kB-bind-
ing site and analyzed by EMSA. Geno-
types are shown at the top. The
addition of specific antisera against the
different members of the NF-kB/Rel
family is indicated at the bottom. p.i.,
Preimmune serum. p50 homodimers
(I) as well as p50-RelA, p50-RelB,
and p52-RelB heterodimers (II) are
indicated at the left. The same extracts
were incubated with an octamer bind-
ing site (Oct) to demonstrate similar
amounts of DNA-binding activity
(lanes  13–16). (B) Analysis of NF-kB/
Rel complexes in activated extracts.
Thymus extracts from wild-type,
p502/2,  relB2/2, and p502/2relB2/2
mice were incubated with a palindro-
mic  kB-binding site in the absence
(lane  1–4) or presence (lanes 5–16) of
0.6% DOC. Genotypes are shown at
the top. The addition of specific anti-
sera against the different members of
the NF-kB/Rel family is indicated at
the bottom. p.i., Preimmune serum.
p50 homodimers (I) p50-RelA, p50-
RelB, and p52-RelB heterodimers (II)
as well as RelA-c-Rel complexes and
c-Rel homodimers (III) are indicated
at the left.1368 Severely Increased Pathology in p502/2relB2/2 Double-knockout Mice
have recently demonstrated that both multiorgan inflam-
mation and myeloid hyperplasia in RelB-deficient mice are
T cell–dependent (43). This result correlates with the finding
that the inflammatory infiltrates in 10–20-d-old relB2/2
single- and p502/2relB2/2 double-knockout mice predom-
inantly consisted of CD41 and CD81 T cells. In thymus,
RelB expression is restricted to medullary DC and epithe-
lial cells (15, 21, 22), cell types that have been implicated in
the process of negative selection (44, 45). Since develop-
ment of thymic medulla is impaired in the absence of RelB,
a defect in clonal deletion of autoreactive T cells may even-
tually result in potentially pathogenic T cells promoting the
inflammatory phenotype observed in RelB-deficient mice.
This model is further supported by the finding that relB2/2
mice poorly delete autoreactive thymocytes and have spleno-
cytes that generate an autoreactive response (46).
The thymus of p502/2 mice is nonremarkable and T cell
development is not impaired in these animals (8). Despite
thymic atrophy and impaired development of a thymic me-
dulla, RelB-deficient mice have normal thymocyte subsets
as defined by CD4, CD8, CD3, CD25, and TCR-a/b
surface markers (21). Simultaneous disruption of p50 and
RelB, however, resulted in a markedly increased thymic
atrophy with a 10–20-fold reduction in cellularity, the
complete absence of a medullary compartment, and an al-
tered profile of thymocyte subpopulations. Consistent with
the thymocyte profile, mature CD41 and CD81 single
positive cells could be detected in peripheral lymphoid or-
gans and inflammatory infiltrates of double-knockout ani-
mals, indicating that T cell differentiation is not blocked in
the absence of both p50 and RelB. The basis for the lack of
immature CD41CD81 DP thymocytes in 3-wk-old p502/2
relB2/2 mice is not clear. Interestingly, very similar changes
in thymus have been observed in mice lacking the pro-
tooncogene c-fos (47). The drastic reduction in the number
of CD41CD81 DP thymocytes occurs only in 40–50% of
the c-fos2/2 mice, and it has been suggested that this defect
could be an indirect consequence of impaired bone mar-
row function and general stress on these animals (48). Sim-
ilar mechanisms may be responsible for the dramatic reduc-
tion in the number of DP thymocytes in mice lacking both
p50 and RelB.
Role of B Cells, Macrophages, and Neutrophils. B cell de-
velopment in relB2/2 mice appears normal and B cells lack-
ing RelB undergo normal maturation to Ig secretion and Ig
class switching, but they have decreased proliferative re-
sponses (21, 49). Immunohistochemical analysis of tissue sec-
tions revealed that B cells are a prominent component of
the inflammatory infiltrates in relB2/2 single-mutant ani-
mals. Similar to RelB, p50 is not required for normal B cell
development (8). However, purified B cells from p50-defi-
cient mice have selective defects in proliferation, differenti-
ation, germ-line CH transcription, and Ig class switching
(9). In contrast to relB2/2 single mutants, p502/2relB2/2
double-mutant mice did not have significant numbers of B
cells in inflamed tissues despite markedly increased severity
of the phenotype. This result correlates with impaired B
cell development resulting in markedly reduced numbers of
both immature B2201IgM2 and mature B2201IgM1 B cells
in bone marrow and spleen of double-knockout mice. Thus,
B cells appear not to be required for the development of
the multiorgan inflammation, although we cannot rule out the
possibility that B cells may modulate the inflammatory re-
sponse in RelB-deficient mice. Further studies, such as in
vitro  differentiation and bone marrow reconstitution exper-
iments, are required to understand the developmental poten-
tial of T and B cells from p502/2relB2/2 mice in more detail.
We also analyzed the contribution of myeloid cells to the
inflammatory infiltrate using mAbs specific for macrophages
(F4/80) and neutrophils (7/4). In 20-d-old animals, only
very few F4/801 cells were present in the inflammatory in-
filtrates of both relB2/2 single- and p502/2relB2/2 double-
knockout mice. In 5–6-week-old relB2/2 single mutants,
however, positive F4/80 staining could be detected in the
inflammatory infiltrates of liver and lung (data not shown),
suggesting that macrophages are not playing a major role
during the early stages of the inflammatory phenotype. The
faint F4/80 staining of sinusoidal Kupffer cells is most likely
due to an activated state of these tissue macrophages trig-
gered by the inflammatory infiltrates, since it has been
shown that F4/80 expression is significantly reduced upon
antigen stimulation and activation (50). In contrast to mac-
rophages, mature neutrophils contribute to the inflamma-
tory infiltrate in 20-d-old single- and, in particular, double-
knockouts. This finding correlates with a marked increased
of neutrophils in bone marrow and spleen of p502/2relB2/2
mice compared to relB2/2 animals. The cause of this prom-
inent neutrophilia is still unclear. One possible explanation
is that polymorphonuclear leukocytes become activated by
cytokines released by autoreactive T cells, a scenario that is
supported by an altered cytokine milieu in mice lacking
RelB and an attenuated myeloid hyperplasia in T cell–defi-
cient relB2/2 mice (21a and 43).
The phenotypic changes in p502/2relB2/2 double-
knockout and p502/2relB2/1 mice, compared to the respec-
tive single-knockout and relB2/1 animals, indicate that the
lack of RelB is partially compensated by other p50-con-
taining complexes. Our results also show that the classical
p50-RelA–NF-kB activity is not required for the develop-
ment of the multiorgan inflammatory phenotype. Addi-
tional NF-kB/Rel double-knockout mice may give further
insight into both functional redundancy and specificity
within this family.
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